Table 1 MSK Model Information Sheet questions (2024 version)

From: Responsible Artificial Intelligence governance in oncology

Category

Requested Information

General

MSK Business Sponsor

MSK Business Lead

Strategic Alignment Category

Impacted Users

Primary Function/Objective

Expected Benefits (Use/Impact metrics)

Development Team

Development Staff Members

Link(s) to model documentation

Key words (tags for search within Registry)

Is this an externally acquired solution (vendor)?

Technical

System of Use/Record (i.e., where users will experience it)

Data Sources Used

Does it have PHI?

Does it have PII?

Is it subject to GDPR?

Model Training Methods/Model Type

Model Performance Metrics

Development Platform

Github Link to code

IRB link (if applicable)

Fairness Assessment Method

FDA SaMD Screening

Info Type: Communicable in normal clinical conversation?

Output: Gives clinician directive or recommendation?

Disclosure to Clinician: Gives basis for recommendation? Dynamic or “learning” algorithm?

FDA SaMD Determination

Other Regulatory Determination TBD (e.g., State regs, ONC, NIST, etc.)

Approval Status

Silent Pilot Approval

Full Production Launch Approval

Anticipatable AI-induced Adverse Events (aiAE’s)

How often is performance re-evaluation required?

Last post-launch date/status of review of relevant research and evidence

  1. IRB institutional review board, PHI personal health information, PII personal identifying information, GDPR general data protection regulation, FDA SaMD Federal Drug Administration Software as a Medical Device, ONC Office of the National Coordinator, NIST National Institute of Standards and Technology, aiAE’s AI-induced adverse events.
  2. Source: Memorial Sloan Kettering.
  3. Required questions to complete a model’s registration by AI developers (both built and acquired models) are shown below, and are completed in collaboration with the AI Governance Committee staff.